Logo image
Suppressive CD8+ T-Cells Are Key Cellular Mediators of Extracorporeal Photopheresis
Journal article   Open access   Peer reviewed

Suppressive CD8+ T-Cells Are Key Cellular Mediators of Extracorporeal Photopheresis

Kai J Rogers, Kathryn L Eschbacher, Zeb Zacharias, Kshitija Kale, Michael P Crawford, Charles Michael Knudson, Alexander W Boyden and Nitin J Karandikar
Journal of clinical apheresis, Vol.41(1), e70094
02/01/2026
DOI: 10.1002/jca.70094
PMCID: PMC12882035
PMID: 41653030
url
https://doi.org/10.1002/jca.70094View
Published (Version of record) Open Access

Abstract

Extracorporeal photopheresis (ECP) is a widely utilized immunomodulatory procedure with an incompletely defined mechanism. In graft-versus-host disease (GvHD) and transplant rejection, ECP is thought to induce immune tolerance by increasing regulatory CD4+ T-cells, whereas in cutaneous T cell lymphoa it may enhance dendritic cell-mediated antigen presentation and cytotoxic T cell activity. We investigated the role of CD8+ T cells in ECP using a murine model of multiple sclerosis (MS). ECP protected mice from disease, mitigated CNS pathology, and was dependent on CD8+ T cells. Translation to patients revealed increased numbers of suppressive CD8+ T-cells. Functional assays identified enhanced suppressive capacity of CD8+ T-cells in ECP patients and longitudinal studies found this occurred within 1 month of starting ECP. Using both a murine model and clinical samples, our findings reveal a mechanistic role for suppressive CD8+ T-cells in mediating the effects of ECP, potentially providing a unifying mechanism for ECP's apparently dichotomous effects.
Animals CD8-Positive T-Lymphocytes - immunology Disease Models, Animal Female Graft vs Host Disease Humans Immune Tolerance Male Mice Mice, Inbred C57BL Multiple Sclerosis - immunology Multiple Sclerosis - therapy Photopheresis - methods

Details

Metrics

1 Record Views
Logo image